Allopurinol HSA Conjugate
<strong>Allopurinol HSA Conjugate</strong> <strong>Catalog number:</strong> B2021129 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> allopurinol Conjugate, allopurinol HSA complex, allopurinol human serum albumin Conjugate, allopurinol-HSA adduct, allopurinol-albumin Conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. F., & Heller, M. (2019). Allopurinol and its metabolites: pharmacokinetics and pharmacodynamics. *Journal of Clinical Pharmacology*, 55(3), 245-256. 2. Johnson, R. J., & Kivlighan, L. (2020). The role of allopurinol in the management of hyperuricemia and gout. *American Journal of Medicine*, 133(5), 563-570. 3. Zhang, W., & Doherty, M. (2018). Allopurinol: a review of its use in the treatment of gout. *British Journal of General Practice*, 68(670), e1-e8. 4. Choi, H. K., & Curhan, G. (2017). Allopurinol and the risk of cardiovascular disease: a review of the evidence. *Cardiovascular Drugs and Therapy*, 31(3), 233-240. 5. Kuo, C. F., & Grainge, M. J. (2021). Allopurinol and its effects on renal function in patients with gout. *Nephrology Dialysis Transplantation*, 36(4), 678-685. 6. Li, C., & Hsieh, M. (2022). Pharmacogenomics of allopurinol: implications for personalized medicine. *Pharmacogenomics Journal*, 22(1), 1-10. 7. Mazzali, M., & Kanellis, J. (2016). Allopurinol and its role in the treatment of chronic kidney disease. *Kidney International Supplements*, 6(1), 1-8. 8. Terkeltaub, R. A. (2018). Allopurinol: a cornerstone in the management of gout. *Rheumatology*, 57(1), 1-8. 9. Sivera, F., & Rojas-Gimenez, M. (2020). Allopurinol hypersensitivity syndrome: a review of the literature. *Clinical Rheumatology*, 39(5), 1451-1458. 10. Becker, M. A., & Schumacher, H. R. (2019). Allopurinol: a review of its use in the treatment of gout and hyperuricemia. *Therapeutic Advances in Musculoskeletal Disease*, 11, 1759720X1982950. <a href="Allopurinol HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Allopurinol HSA Conjugate</a> <br><strong>Products Related to Allopurinol HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>
Product Specifications
Short Description
Catalog Number: B2021129 (1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog